Hyderabad Telangana, India

Suraparaju Raghuram


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Suraparaju Raghuram: Innovator in Benzimidazole Derivatives

Introduction

Suraparaju Raghuram is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of chemistry, particularly in the development of benzimidazole derivatives. With a total of 2 patents to his name, Raghuram continues to push the boundaries of innovation in pharmaceutical chemistry.

Latest Patents

Raghuram's latest patents include a process for the preparation of benzimidazole derivatives and salts thereof. This patent provides novel salts of benzimidazole derivatives, which are useful intermediates in the synthesis of pure 1-methyl-2-[N-[4-(N-n-hexyloxycarbonylamidino)phenyl]aminomethyl]benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide and its salts. Another significant patent involves a process for the preparation of benzimidazole derivatives and its salts, specifically focusing on a dabigatran etexilate intermediate of Formula-6a, which is used in the preparation of dabigatran etexilate.

Career Highlights

Suraparaju Raghuram is currently associated with Msn Laboratories Private Limited, where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing the synthesis of important chemical compounds that have potential therapeutic applications.

Collaborations

Raghuram has collaborated with several talented individuals in his field, including Srinivasan Thirumalai Rajan and Sajja Eswaraiah. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Suraparaju Raghuram stands out as a dedicated inventor in the realm of benzimidazole derivatives. His contributions to the field of chemistry are noteworthy, and his ongoing work promises to yield further advancements in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…